US · Healthcare

Paradigm Biopharmaceuticals Limited (PBIGF)

Biotechnology

Paradigm Biopharmaceuticals Limited (PBIGF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for PBIGF

P/E ratio

18.00

Paradigm Biopharmaceuticals Limited (PBIGF) — FAQ

What is PBIGF's P/E ratio?

The price-to-earnings (P/E) ratio for Paradigm Biopharmaceuticals Limited (PBIGF) is 18.00 (data as of 2026-03-25).

Does Paradigm Biopharmaceuticals Limited pay a dividend?

Dividend yield is not available in the current snapshot for Paradigm Biopharmaceuticals Limited (PBIGF). Check the MyAverix Finance app for the latest dividend data.

What sector is Paradigm Biopharmaceuticals Limited in?

Paradigm Biopharmaceuticals Limited (PBIGF) is classified in the Healthcare sector (Biotechnology industry).

What exchange is PBIGF listed on?

PBIGF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)